Literature DB >> 19851270

Analysis of laparoscopic colorectal surgery in high-risk patients.

Ziya Salihoglu1, Bilgi Baca, Selcuk Koksal, Ismail Hakki Hamzaoglu, Tayfun Karahasanoglu, Saliha Avci, Volkan Ozben.   

Abstract

The aim of this retrospective study is to examine the feasibility and safety of laparoscopic colorectal resection for colorectal malignancies to determine "high-risk" patients. In our classification, 3 minor criteria including patients over 70 years of age, body mass index over 30 m/kg, and cigarette smoking and 5 major criteria including cardiac, pulmonary, renal, liver disease, and diabetes mellitus were selected to determine a high-risk group. Patients carrying 1 minor and 1 major criteria were classified as the high-risk group. Concerning patients and operations, hemodynamic values (mean arterial systolic and diastolic pressures and heart rates), oxygen saturations, end-expiratory carbon dioxide levels, respiratory mechanics (dynamic compliance, peak inspiratory pressure, airway resistance) were analyzed. Cardiovascular system (myocardial infarction, arrhythmia, hypertension), pulmonary system (respiratory insufficiency), digestive system (anastomotic leak, fistula, and paralytic ileus), fever, thrombophlebitis, urinary infections, wound infections, and central nervous system (delirium and cerebrovascular accident) were also investigated. A total number of 85 high-risk patients were included in the study. Gastrointestinal leaks in 2.3%, fistula in 1.1%, ileus in 3.5%, postoperative bleeding in 2.3%, postoperative fever in 5.8%, wound infection in 5.8%, and cerebrovascular accidents in 1.1% of patients were detected. The lowest values of hemodynamic and respiratory mechanics were observed at the induction of pneumoperitoneum and in this period the compliance and mean arterial pressure were determined to be 36+/-14 mm Hg and 84+/-14 mm Hg, respectively. No mortalities occurred. In experienced hands, laparoscopic colorectal resection can be performed safely for "high-risk" surgical patients.

Entities:  

Mesh:

Year:  2009        PMID: 19851270     DOI: 10.1097/SLE.0b013e3181bb4b65

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  6 in total

1.  Two clinically relevant pressures of carbon dioxide pneumoperitoneum cause hepatic injury in a rabbit model.

Authors:  Jun Li; Ying-Hai Liu; Zhan-Yong Ye; He-Nian Liu; Shan Ou; Fu-Zhou Tian
Journal:  World J Gastroenterol       Date:  2011-08-21       Impact factor: 5.742

2.  Risk criteria for scientific researches. For whom the bell tolls?

Authors:  Ziya Salihoglu; Tarik Umutoglu; Mefkur Bakan
Journal:  J Gastrointest Surg       Date:  2014-06-19       Impact factor: 3.452

3.  Laparoscopic surgery improves postoperative outcomes in high-risk patients with colorectal cancer.

Authors:  Francesco Feroci; Maddalena Baraghini; Elisa Lenzi; Alessia Garzi; Andrea Vannucchi; Stefano Cantafio; Marco Scatizzi
Journal:  Surg Endosc       Date:  2012-10-06       Impact factor: 4.584

4.  A nationwide analysis of laparoscopy in high-risk colorectal surgery patients.

Authors:  Celeste Y Kang; Wissam J Halabi; Obaid O Chaudhry; Vinh Nguyen; Noor Ketana; Joseph C Carmichael; Alessio Pigazzi; Michael J Stamos; Steven Mills
Journal:  J Gastrointest Surg       Date:  2012-12-01       Impact factor: 3.452

5.  Long-term outcomes and propensity score matching analysis: rectal cancer resection for patients with elevated preoperative risk.

Authors:  Hao Feng; Tobias S Schiergens; Zhi-Hai Mao; Jingkun Zhao; Xiaohui Shen; Ai-Guo Lu; Wolfgang E Thasler
Journal:  Oncotarget       Date:  2017-04-11

6.  Clinical outcome of laparoscopic vs open right hemicolectomy for colon cancer: A propensity score matching analysis of the Japanese National Clinical Database.

Authors:  Takeru Matsuda; Hideki Endo; Masafumi Inomata; Hiroshi Hasegawa; Hiraku Kumamaru; Hiroaki Miyata; Yoshiharu Sakai; Yoshihiro Kakeji; Yuko Kitagawa; Masahiko Watanabe
Journal:  Ann Gastroenterol Surg       Date:  2020-08-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.